Avid Bioservices Inc (CDMO)

[biopharm]

That new medical device ( re: Brigitte Phan/Donald Bollella / Ramon Valencia) probably has the new BP player for Peregrine every so anxious to stryker a deal

Many eyes and ears on the ground near Stryker in malvern, PA ... because looks like some interesting names begin to apear and all focused on PS Targeting so which way will PS Targeting move towards

Stryker Ortho Biologics to Fujirebio Diagnostics to 300 Technology Drive (Gerald Finkens reward) to 200 Great Valley Parkway (Janssen ex-Centocor) and I'd rather just see J.Carl Barrett of AstraZeneca reveal what PS Targeting biomarkers are all about in Feb but we may hear some surprises before then

http://www.mnmconferences.com/The-Biomarker-Conference#Speakers

---------------------------------------------------------

So much on the line for Big Pharmas and I suspect one of them will make a move, just knowing that the MOA of many protein pathways will prove PS Targeting is the #1 priority

Phosphatidylserine exposure during apoptosis precedes release of cytochrome c and decrease in mitochondrial transmembrane potential.